Science Explorer Back to mapMap
Discussion
Research facility · Waterloo · Canada

Probity Medical Research

In research, Probity Medical Research stands highest in Health Sciences (#4,903 of 16,688 worldwide) and Medicine (#5,778 of 14,558 worldwide), over all time.

probitymedical.comROR OpenAlex
World rank, 2022-now
#21,172
of 22,385 · #19,241 all time
Rank in Canada
#290
of 305
Research works
208
▲ 37% vs 2018-21
Citations
8.7k
41.8 per fractional work
Top-10% rate
13.0%
all institutions 10.0%
vs its own fields
1.00×
1.00× is exactly expected
Open access
47%
world 40%
International
67%
world 18%
Probity Medical Research

What is Probity Medical Research known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #4,903 of 16,688 19.1%123
MedicineField #5,778 of 14,558 19.2%121

Each strip is that field's whole ranked pool, with the notch where Probity Medical Research sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Probity Medical Research work in?

In 2022-now, 62% of research at Probity Medical Research is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (61%), Immunology and Microbiology (23%), Biochemistry, Genetics and Molecular Biology (6%). It does 2.4× the world's share of Health Sciences.

Health Sciences: 51 fractional works · 61.9% of its workMedicine: 50 fractional works · 60.8% of its workDermatology: 18 fractional works · 21.5% of its workRheumatology: 8 fractional works · 10.1% of its workPathology and Forensic Medicine: 4 fractional works · 4.7% of its workImmunology and Allergy: 3 fractional works · 4.2% of its workPhysiology: 3 fractional works · 3.7% of its workPediatrics, Perinatology and Child Health: 3 fractional works · 3.2% of its workOncology: 2 fractional works · 2.7% of its workEpidemiology: 2 fractional works · 2.0% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.6% of its workPharmacology: 1 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.8% of its workGenetics: 1 fractional works · 0.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 0.7% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.7% of its workHematology: 1 fractional works · 0.7% of its workSurgery: 0 fractional works · 0.6% of its workUrology: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.4% of its workPsychiatry and Mental health: 0 fractional works · 0.3% of its workRehabilitation: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.7% of its workHealth Professions: 0 fractional works · 0.5% of its workEmergency Medical Services: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.4% of its workPeriodontics: 0 fractional works · 0.4% of its workVeterinary: 0 fractional works · 0.2% of its workSmall Animals: 0 fractional works · 0.2% of its workLife Sciences: 26 fractional works · 31.7% of its workImmunology and Microbiology: 19 fractional works · 23.2% of its workImmunology: 19 fractional works · 23.2% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 5.8% of its workMolecular Biology: 2 fractional works · 2.6% of its workCell Biology: 1 fractional works · 1.1% of its workBiotechnology: 1 fractional works · 1.0% of its workGenetics: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 1 fractional works · 1.4% of its workPlant Science: 1 fractional works · 0.9% of its workInsect Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.9% of its workPharmacology: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.5% of its workBiological Psychiatry: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 4 fractional works · 4.3% of its workEconomics, Econometrics and Finance: 2 fractional works · 2.2% of its workEconomics and Econometrics: 1 fractional works · 1.6% of its workFinance: 0 fractional works · 0.6% of its workBusiness, Management and Accounting: 1 fractional works · 0.9% of its workAccounting: 0 fractional works · 0.4% of its workStrategy and Management: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDecision Sciences: 1 fractional works · 0.7% of its workManagement Science and Operations Research: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.4% of its workGender Studies: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 0.1% of its workPhysical Sciences: 2 fractional works · 2.1% of its workEngineering: 1 fractional works · 0.7% of its workMechanical Engineering: 0 fractional works · 0.3% of its workOcean Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 0 fractional works · 0.4% of its workArtificial Intelligence: 0 fractional works · 0.4% of its workMaterials Science: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 0.2% of its workOrganic Chemistry: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.2% of its workPollution: 0 fractional works · 0.2% of its workEnergy: 0 fractional works · 0.1% of its workALL ITS WORKProbity MedicalResearch82fractional works, 2022-now
Life Sciences32%Physical Sciences2%Health Sciences62%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine5060.8%
    2. Health Professions00.5%
    3. Dentistry00.4%
    4. Veterinary00.2%
    1. Immunology and Microbiology1923.2%
    2. Biochemistry, Genetics and Molecular Biology55.8%
    3. Agricultural and Biological Sciences11.4%
    4. Pharmacology, Toxicology and Pharmaceutics10.9%
    5. Neuroscience00.5%
    1. Economics, Econometrics and Finance22.2%
    2. Business, Management and Accounting10.9%
    3. Decision Sciences10.7%
    4. Social Sciences00.4%
    5. Psychology00.1%
    1. Engineering10.7%
    2. Computer Science00.4%
    3. Materials Science00.3%
    4. Chemistry00.2%
    5. Environmental Science00.2%
    6. Energy00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.30× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.08× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 23.05× its world share, 19 worksImmunology and Micro…Neuroscience: 0.28× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.43× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.16× its world share, 0 worksChemistryComputer Science: 0.05× its world share, 0 worksComputer ScienceEnergy: 0.15× its world share, 0 worksEnergyEngineering: 0.05× its world share, 1 worksEngineeringEnvironmental Science: 0.04× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.09× its world share, 0 worksMaterials ScienceDentistry: 0.81× its world share, 0 worksDentistryHealth Professions: 0.19× its world share, 0 worksHealth ProfessionsMedicine: 3.16× its world share, 50 worksMedicineVeterinary: 1.80× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.27× its world share, 1 worksBusiness, Management…Decision Sciences: 0.69× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.05× its world share, 2 worksEconomics, Econometr…Psychology: 0.03× its world share, 0 worksPsychologySocial Sciences: 0.03× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 23.1×. Every wedge is a field page.

All 20 fields, with their numbers
  1. Immunology and Microbiology23.05×19 works
  2. Medicine3.16×50 works
  3. Pharmacology, Toxicology and Pharmaceutics2.43×1 works
  4. Veterinary1.80×0 works
  5. Biochemistry, Genetics and Molecular Biology1.08×5 works
  6. Economics, Econometrics and Finance1.05×2 works
  7. Dentistry0.81×0 works
  8. Decision Sciences0.69×0 works
  9. Agricultural and Biological Sciences0.30×1 works
  10. Neuroscience0.28×0 works
  11. Business, Management and Accounting0.27×1 works
  12. Health Professions0.19×0 works
  13. Chemistry0.16×0 works
  14. Energy0.15×0 works
  15. Materials Science0.09×0 works
  16. Computer Science0.05×0 works
  17. Engineering0.05×1 works
  18. Environmental Science0.04×0 works
  19. Psychology0.03×0 works
  20. Social Sciences0.03×0 works

Who are the top researchers at Probity Medical Research?

Ranked on the quality score, Kim Alexander Papp, Seth B. Forman and Newman M. Yeilding lead among researchers whose main affiliation is Probity Medical Research.

  1. 1 Kim Alexander Papp Canada · #70,455 worldwide 50k citations · 814 works
  2. 2 Seth B. Forman Canada · #126,354 worldwide 6k citations · 118 works
  3. 3 Newman M. Yeilding Canada · #165,349 worldwide 7.4k citations · 44 works
  4. 4 Melinda Gooderham Canada · #226,997 worldwide 16k citations · 582 works
  5. 5 Darryl P. Toth Canada · #476,226 worldwide 3.3k citations · 40 works
  6. 6 Robert M. Day Canada · #487,589 worldwide 3k citations · 48 works
  7. 7 Javier Alonso‐Llamazares Canada · #1,090,908 worldwide 812 citations · 62 works
  8. 8 David A. Krupa Canada · #1,111,463 worldwide 2.4k citations · 101 works
  9. 9 Patrick Burnett Canada · #1,176,253 worldwide 917 citations · 102 works
  10. 10 Mark A. Lomaga Canada · #1,420,904 worldwide 2k citations · 21 works
All ranked researchers at Probity Medical Research

What are the most cited papers from Probity Medical Research?

The most cited paper from Probity Medical Research is "Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials" (Richard G B Langley, Boni Elizabeth Elewski, Mark Lebwohl et al., 2014), with 2,004 citations. Next come "Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)" (1,876) and "Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)" (1,365).

Most cited papers
#PaperReleasedCitations
1 Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials Richard G B Langley, Boni Elizabeth Elewski, Mark Lebwohl et al. · New England Journal of Medicine Open access 9 Jul 2014 2,004
2 Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1) Craig L. Leonardi, Alexa B. Kimball, Kim Alexander Papp et al. · The Lancet May 2008 1,876
3 Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) Kim Alexander Papp, Richard G B Langley, Mark Lebwohl et al. · The Lancet May 2008 1,365
4 Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial Andrew Blauvelt et al. · The Lancet Open access 4 May 2017 1,269
5 Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial Stephen Keith Tyring, Alice Bendix Gottlieb, Kim Alexander Papp et al. · The Lancet 22 Dec 2005 1,075
All 60 most cited papers, with filters and sorting

Which keywords describe research at Probity Medical Research?

By fractional works in 2022-now, weighted toward what it does more of than the world: TGF-ß, Regulatory T Cells, Immune System, IL-17, TH17 Cells, Immune Dysregulation, Filaggrin and Skin Microbiome.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. TGF-ß18▲ 135×2 topics
  2. Regulatory T Cells17▲ 179×2 topics
  3. Immune System17▲ 87×3 topics
  4. IL-1717▲ 575×1 topic
  5. TH17 Cells17▲ 575×1 topic
  6. Epidemiology15▲ 4.6×22 topics
  7. Immune Dysregulation13▲ 195×2 topics
  8. Filaggrin12▲ 297×1 topic
  9. Skin Microbiome12▲ 297×1 topic
  10. Diagnosis9▲ 11×9 topics
  11. Inflammation8▲ 4.7×15 topics
  12. Autoantibodies8▲ 40×6 topics
  13. Quality of Life7▲ 6.2×9 topics
  14. Autoimmune6▲ 160×2 topics
  15. Treatment5▲ 5.3×10 topics
  16. Immunosuppressive Therapy5▲ 31×5 topics
  17. Asthma5▲ 59×2 topics
  18. Management4▲ 6.5×5 topics
  19. Ankylosing Spondylitis4▲ 162×1 topic
  20. Rituximab4▲ 32×3 topics
  21. Spondyloarthritis4▲ 162×1 topic
  22. Genetics4▲ 6.6×3 topics
  23. Bullous Pemphigoid4▲ 173×1 topic
  24. Pemphigoid4▲ 173×1 topic
  25. Immunology3▲ 35×2 topics
  26. Clinical Trials3▲ 5.5×6 topics
  27. Allergic Diseases3▲ 59×1 topic
  28. Eosinophils3▲ 59×1 topic
  29. Adverse Drug Reactions3▲ 63×2 topics
  30. Drug Development3▲ 38×2 topics
  31. Off-Label Drug Use3▲ 124×1 topic
  32. Pediatric Pharmacokinetics3▲ 124×1 topic
  33. Chronic Spontaneous Urticaria2▲ 144×1 topic
  34. Urticaria2▲ 144×1 topic
  35. Cytokines2▲ 9.4×3 topics
  36. Allergen-specific Immunotherapy2▲ 75×1 topic
  37. Pollen Allergy2▲ 75×1 topic
  38. Rheumatoid Arthritis2▲ 21×3 topics
  39. Genetic Susceptibility2▲ 21×2 topics
  40. Anaphylaxis2▲ 79×1 topic

Which research topics does Probity Medical Research publish most on?

By volume in 2022-now: Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Spondyloarthritis Studies and Treatments and Autoimmune Bullous Skin Diseases.

Psoriasis: Treatment and…17Psoriasis: Treatment and Pathogenesis: 17 fractional worksDermatology and Skin Dis…12Dermatology and Skin Diseases: 12 fractional worksSpondyloarthritis Studie…4Spondyloarthritis Studies and Treatments: 4 fractional worksAutoimmune Bullous Skin …4Autoimmune Bullous Skin Diseases: 4 fractional worksAsthma and respiratory d…3Asthma and respiratory diseases: 3 fractional worksPharmaceutical studies and practices: 3 fractional worksUrticaria and Related Conditions: 2 fractional worksAllergic Rhinitis and Sensitization: 2 fractional worksFood Allergy and Anaphylaxis Research: 2 fractional worksCytokine Signaling Pathways and Interactions: 1 fractional works
ImmunologyDermatologyRheumatologyPathology and Forensic Medicine4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Psoriasis: Treatment and Pathogenesis Immunology 17 works
  2. 2 Dermatology and Skin Diseases Dermatology 12 works
  3. 3 Spondyloarthritis Studies and Treatments Rheumatology 4 works
  4. 4 Autoimmune Bullous Skin Diseases Pathology and Forensic Medicine 4 works
  5. 5 Asthma and respiratory diseases Physiology 3 works
  6. 6 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 3 works
  7. 7 Urticaria and Related Conditions Rheumatology 2 works
  8. 8 Allergic Rhinitis and Sensitization Immunology and Allergy 2 works
  9. 9 Food Allergy and Anaphylaxis Research Immunology and Allergy 2 works
  10. 10 Cytokine Signaling Pathways and Interactions Oncology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.8%not open53.2%

World: 40% of research is openly available.

with international co-authors66.7%domestic only33.3%

World: 18% is written across borders.

How has Probity Medical Research's research output changed?

Output in 2022-2025 was 37% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Probity Medical Research as a percentage of every work published that year, 0.00038% in 2024.

still counting0.00020%0.00040%Probity Medical Research0.00033% in 20251990200020102020

Fractional works of Probity Medical Research over all fractional works that year. How the balance of science has shifted.

Other research institutions in Waterloo

All research institutions in Waterloo

Share Probity Medical Research's ranking

Probity Medical Research on Science Explorer

A card with Probity Medical Research's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Probity Medical Research. Posts are plain text and can be reported.